OJEMAN CORTICAL STIMULATOR OCS2

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2016-05-17 for OJEMAN CORTICAL STIMULATOR OCS2 manufactured by Integra Burlington, Ma, Inc..

Event Text Entries

[46583405] A report was received that on (b)(6) 2015, the ocs2 ojeman cortical stimulator had no output current. It was reported that it was an out of box failure (device was purchased on (b)(6) 2015) and it was unknown if the device was in contact with a patient. When it was tested, there was no output current. The batteries were changed and the battery indicator on the unit was at the highest level. A revision/medical intervention was required however details were not provided at the time of this report. The patient was prepped for surgery and there was delay in surgery due to the product problem however the amount of time was not provided. The device had been used approximately 6-8 times since being purchased and received. Additional information was requested.
Patient Sequence No: 1, Text Type: D, B5


[53567961] Integra has completed their internal investigation on 09 aug 2016. The investigation included: methods: evaluation of actual device, review of device history records, review of complaint history. Results: evaluation of device: one oc2 was received in billerica on 05/13/2016. The serial number was reported as being (b)(4) which was incorrect, the correct serial number is (b)(4). A visual inspection of the returned product found visual damage on both the front and back left corners of the ocs2. Customer states the unit has no output reading. This issue is due to the transformer breaking off of the printed circuit board. The printed circuit board cannot be repaired - will require replacement board before calibrating the dhr review verified all the functionality tests were carried out accordingly and all results of the tests were recorded as within specification prior to the ocs2 been released. No nonconformance reports were raised during the manufacturing process for these monitors. Manufacture date: dec-2007. A two year complaint look back was performed in trackwise for the ocs2. In the prior two years, 21 complaint, including this complaint, have been received on the ocs2. No additional complaints were received with the reported failure? No output current". No adverse trend is identified at this time. Conclusion: the internal component coming loose was likely caused by physical damage to the unit. The ocs2 was repaired, recalibrated and returned to the customer.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1222895-2016-00005
MDR Report Key5660701
Date Received2016-05-17
Date of Report2016-04-19
Date of Event2006-02-25
Date Mfgr Received2016-08-09
Device Manufacturer Date2007-12-01
Date Added to Maude2016-05-17
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationBIOMEDICAL ENGINEER
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactUSER BINA PATEL
Manufacturer Street311 ENTERPRISE DRIVE
Manufacturer CityPLAINSBORO NJ 08536
Manufacturer CountryUS
Manufacturer Postal08536
Manufacturer Phone6099362393
Manufacturer G1INTEGRA BURLINGTON, MA, INC.
Manufacturer Street22 TERRY AVENUE
Manufacturer CityBURLINGTON MA 01803
Manufacturer CountryUS
Manufacturer Postal Code01803
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameOJEMAN CORTICAL STIMULATOR
Generic NameN/A
Product CodeGYC
Date Received2016-05-17
Returned To Mfg2016-05-12
Catalog NumberOCS2
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerINTEGRA BURLINGTON, MA, INC.
Manufacturer Address22 TERRY AVENUE 22 TERRY AVENUE BURLINGTON MA 01803 US 01803


Patients

Patient NumberTreatmentOutcomeDate
10 2016-05-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.